Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adherence of a 1.600 mg Single Tablet 5-ASA Treatment of Ulcerative Colitis (EASI-trial)

NCT04133194 is registered in ClinicalTrials.gov with Flemming Bendtsen as lead sponsor.

NCT NCT04133194
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04133194 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adherence of a 1.600 mg Single Tablet 5-ASA Treatment of Ulcerative Colitis (EASI-trial)
Lead sponsor
Flemming Bendtsen
Phase
Phase 4
Overall status
Unknown status
Start date
November 28, 2019
Completion date
March 1, 2025
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis